MELSUNGEN, GERMANY and MONMOUTH JUNCTION, N.J. (OTS) - Joint marketing of CytoSorb® with B. Braun’s newest OMNI® blood purification platform will offer greater access of this advanced treatment of deadly inflammation to critically ill patients.
B. Braun Avitum AG, a leading manufacturer of medical devices and pharmaceutical products and services and CytoSorbents Corporation (NASDAQ: CTSO),a critical care immunotherapy leader commercializing its CytoSorb® blood...
quelle: OTS